Gilead Sciences (GILD Stock): Finding sector opportunities in the S&P500 [Video]
|Generally speaking, two sectors that do well in a US recession are consumer staples and healthcare stocks. Although consumer disposable income may fall people will still make consumer staple purchases, often in more discount focus stores like Walmart and Costco. The health care sector still remains robust in a recession since consumers still keep up health care payments and prioritise health treatments as far as possible.
You can use Seasonax to screen these different sectors of the S&P500 in order to find strong seasonal patterns like in Gilead Sciences, an American biopharmaceutical company. Over the last 10 years, Gilead Sciences had an annualised return of 47.12%.
Major trade risks: The major risks are from any particularly negative news for Gilead sciences.
Learn more about HYCM
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.